Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

Clicks: 366
ID: 117087
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Twenty-one consecutive patients with streptococcal toxic shock syndrome (TSS) between December 1994 and April 1995 were treated with a median dose of 2 g of intravenous immunoglobulin (IVIG)/kg (cases) and were compared with 32 patients with streptococcal TSS between 1992 and 1995 who did not receiv …
Reference Key
r1999clinicalintravenous Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kaul R;McGeer A;Norrby-Teglund A;Kotb M;Schwartz B;O'Rourke K;Talbot J;Low DE;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10825042
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't u.s. gov't non-p.h.s. female male middle aged Comparative Study P.H.S. immunoglobulins intravenous / therapeutic use* case-control studies neutralization tests streptococcal infections / microbiology analysis of variance shock streptococcal infections / drug therapy* septic / microbiology pmid:10825042 doi:10.1086/515199 r kaul a mcgeer d e low apache mitogens / physiology septic / drug therapy* streptococcus pyogenes* / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.